BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 3, 2016
View Archived Issues
BioLineRx in-licenses liver fibrosis drug candidate
Read More
Novartis patents angiotensin receptor antagonists
Read More
University of Occupational and Environmental Health and Yakult Honsha disclose ZNF143 inhibitors
Read More
Evelo Biosciences, Mayo Clinic to collaborate on immuno-microbiome-based therapies for cancer
Read More
Pivotal phase III ATLANTIS study of PharmaMar's lurbinectedin begins
Read More
FDA grants orphan drug designation to Agilis Biotherapeutics' AGIL-FA
Read More
REGENXBIO's RGX-121 wins FDA rare pediatric disease designation
Read More
Divestiture of Allergan's generic business to Teva complete
Read More
Long-term safety of CERE-120 in patients with Parkinson's disease
Read More
Meda shareholders accept Mylan offer
Read More
Regeneron and Adicet Bio enter collaboration to develop next-generation immune cell therapeutics
Read More
ContraVir Pharmaceuticals' tenofovir analogue for HBV safe and well tolerated in phase Ib study
Read More
Daiichi Sankyo profiles pipeline progress of first quarter of fiscal 2016
Read More
AbbVie reports key events from second quarter 2016
Read More
GeoVax awarded contract from NIH to further develop HIV vaccine
Read More
BARDA awards contract to Altimmune for anthrax vaccine candidate
Read More
Abeona Therapeutics gives update on phase I/II study of MPS IIIA treatment
Read More
HTIT makes milestone payment to Oramed for oral insulin product
Read More
Shionogi transfers 21 long-listed drugs to Lupin's subsidiary Kyowa in Japan
Read More
Novartis' LEE-011 receives FDA breakthrough therapy designation
Read More
Keytruda approved in Europe for patients with advanced NSCLC whose tumors express PD-L1
Read More
Human commensals found to produce a novel antibiotic
Read More
CDC Zika MAC-ELISA test now available to commercial laboratories
Read More
Activity of secukinumab on brain lesions in RRMS
Read More